Literature DB >> 32651806

Alternative Clinical Indications of Botulinum Toxin.

Tina S Alster1, Iris S Harrison2.   

Abstract

Botulinum toxin type A (BoNTA) is a powerful neurotoxin that inhibits acetylcholine release from presynaptic vesicles. The potency and safety profile of BoNTA grant the toxin vast therapeutic potential. It has been used off-label for a variety of dermatologic conditions. This review aims to analyze published literature regarding the benefits and risks of the off-label use of BoNTA beyond facial lines, including eccrine hidrocystomas, enlarged pores, keloids and hypertrophic scars, hidradenitis suppurativa, hyperhidrosis, masseter muscle hypertrophy, and salivary gland hypertrophy, among others. A MEDLINE search from January 2000 to December 2019 was conducted on the off-label uses of botulinum toxin in dermatology.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32651806     DOI: 10.1007/s40257-020-00532-0

Source DB:  PubMed          Journal:  Am J Clin Dermatol        ISSN: 1175-0561            Impact factor:   7.403


  3 in total

1.  Dynamic muscle paralytic effects of a novel botulinum toxin A free of neurotoxin-associated proteins.

Authors:  Wu-Chao Liu; Jun-Hui Su; Ya Feng; Xue-Rui Xiang; Li-Zhen Pan; Ying Liu; Lin Ma; Zhi-Yu Nie; Xue-Ping Zhang; Ling-Jing Jin
Journal:  Pharmacol Res Perspect       Date:  2022-06

2.  Use of Botulinum Toxin in Treating Rosacea: A Systematic Review.

Authors:  Hanlin Zhang; Keyun Tang; Yuanzhuo Wang; Rouyu Fang; Qiuning Sun
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-04-30

Review 3.  Botulinum Toxin Type A for the Treatment of Skin Ulcers: A Review Article.

Authors:  Waranaree Winayanuwattikun; Vasanop Vachiramon
Journal:  Toxins (Basel)       Date:  2022-06-14       Impact factor: 5.075

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.